Beam Therapeutics Inc (BEAM) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Beam Therapeutics Inc   (NASDAQ: BEAM)


Beam Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Beam Therapeutics Inc 's ROA in the second quarter of 2026?
Beam Therapeutics Inc recorded a cumulative net loss of $-85 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -5.15%.

However, within the Healthcare sector 267 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 2955, from total ROA ranking in the first quarter of 2026 at 3503.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 70.11 % 0.95 % 49.38 % 23.45 % 20.98 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -85 -65 -80 -415 -399
Return On Assets (TTM) -5.15 % -4.59 % -5.66 % -32.14 % -32.46 %
BEAM's Total Ranking # 2955 # 3503 # 3796 # 3807 # 3866
Total Assets (TTM) in million 2,367 1,481 1,481 1,311 1,391
Seq. Total Assets Change 59.81 % -0.03 % 12.97 % -5.76 % -5.16 %
Seq. Net Income Change - - - - -

BEAM's 5 Years Annual ROA >> Back to BEAM Management Effectiveness >> Compare BEAM ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 28
Sector # 268
Overall # 3013

Return On Assets Statistics
High Average Low
9.24 %
-30.8 %
-903 %
(March 31, 2012)   (Dec 31 2014)





Financial Statements
Beam Therapeutics Inc 's Assets $ 2,367 million BEAM's Balance sheet
Beam Therapeutics Inc 's Income $ -123 million Quarterly BEAM's Income Statement
BEAM's Income by Division See BEAM's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 49.38 % -26 % 10.51 % -10.86 % 286.62 %
Total Assets in million 1,481 992 1,340 1,213 1,360
Y / Y Net Income Change - - - - -
Net Income in million -80 -377 -133 -289 -371
Annual Return On Assets -5.4 % -37.99 % -9.89 % -23.84 % -27.25 %

BEAM's 5 Years Annual ROA >> Back to BEAM Management Effectiveness >> Compare BEAM ROA to its Competitors



More Return On Assets Ratios
BEAM's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BEAM's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BEAM's Competitors
Subscribers only: Roa for Beam Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for BEAM's Customers

You may also want to know
BEAM's Roi BEAM's Inventory Turnover Ratio BEAM's Growth Rates BEAM's Dividend Comparisons
BEAM's Profitability Ratios BEAM's Asset Turnover Ratio BEAM's Dividend Growth
BEAM's Roe BEAM's Valuation Ratios BEAM's Financial Strength Ratios BEAM's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-08-14T08:46:55+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.